Simona Caporali

Rome, 00152, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy.

Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 28, 2024

Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.

Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.

Journal: Pharmacological research

Published: August 19, 2022

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.

Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.

Journal: Cancers

Published: May 26, 2022

Severe endometriosis: low value of AMH did not affect oocyte quality and pregnancy outcome in IVF patients.

Severe endometriosis: low value of AMH did not affect oocyte quality and pregnancy outcome in IVF patients.

Journal: European review for medical and pharmacological sciences

Published: December 04, 2020

Role of the TAp63 Isoform in Recurrent Nasal Polyps.

Role of the TAp63 Isoform in Recurrent Nasal Polyps.

Journal: Folia biologica

Published: January 07, 2020

The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases.

The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases.

Journal: Folia biologica

Published: January 01, 2020

Birt-Hogg-Dubé syndrome, from non-invasive dermatologic assessment to gene testing, molecular and ultrastructural histologic analysis.

Birt-Hogg-Dubé syndrome, from non-invasive dermatologic assessment to gene testing, molecular and ultrastructural histologic analysis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 27, 2019

Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line.

Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line.

Journal: Journal of chemotherapy (Florence, Italy)

Published: November 29, 2019

Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.

Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.

Journal: Molecular oncology

Published: December 31, 2018

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 27, 2018

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

Journal: Oncotarget

Published: August 03, 2017

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.

Journal: Oncotarget

Published: January 06, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026